Synopsys Forecast, price target & analysts
Synopsys Target price 2025 - Analyst rating & recommendation
Synopsys Classifications & Recommendation:
Synopsys Price Target
| Target Price | $596.70 |
| Price | $502.63 |
| Potential | 18.72% |
| Number of Estimates | 24 |
| 24 Analysts have issued a price target Synopsys 2026 . The average Synopsys target price is $596.70. This is 18.72% higher than the current stock price. The highest price target is $690.91 37.46% , the lowest is $507.43 0.96% . | |
| A rating was issued by 27 analysts: 24 Analysts recommend Synopsys to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Synopsys stock has an average upside potential 2026 of 18.72% . Most analysts recommend the Synopsys stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2032
25 Analysts have issued a sales forecast Synopsys 2025 . The average Synopsys sales estimate is $6.9b . This is 10.73% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $7.1b 14.64% , the lowest is $6.3b 0.77% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $6.1b | 15.22% |
|---|---|---|
| 2025 | $6.9b | 12.43% |
| 2026 | $7.7b | 12.25% |
| 2027 | $8.7b | 12.65% |
| 2028 | $9.5b | 9.24% |
| 2029 | $10.7b | 12.54% |
| 2030 | $11.5b | 7.36% |
| 2031 | $12.8b | 11.51% |
| 2032 | $14.2b | 10.55% |
17 Analysts have issued an Synopsys EBITDA forecast 2025. The average Synopsys EBITDA estimate is $2.9b . This is 123.96% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.1b 136.88% , the lowest is $2.8b 109.67% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $1.4b | 2.72% |
|---|---|---|
| 2025 | $2.9b | 114.73% |
| 2026 | $3.4b | 15.24% |
| 2027 | $4.0b | 16.38% |
| 2028 | $4.4b | 12.57% |
EBITDA Margin
| 2024 | 22.39% | 10.85% |
|---|---|---|
| 2025 | 42.76% | 90.98% |
| 2026 | 43.90% | 2.67% |
| 2027 | 45.36% | 3.33% |
24 Synopsys Analysts have issued a net profit forecast 2025. The average Synopsys net profit estimate is $2.4b . This is 9.81% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.5b 14.09% , the lowest is $2.1b 2.37% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $2.3b | 84.03% |
|---|---|---|
| 2025 | $2.4b | 4.95% |
| 2026 | $2.6b | 11.36% |
| 2027 | $3.1b | 16.54% |
Net Margin
| 2024 | 36.94% | 59.72% |
|---|---|---|
| 2025 | 34.48% | 6.66% |
| 2026 | 34.21% | 0.78% |
| 2027 | 35.39% | 3.45% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
24 Analysts have issued a Synopsys forecast for earnings per share. The average Synopsys EPS is $15.31 . This is 10.54% higher than earnings per share in the financial year 2024. The highest EPS forecast is $15.91 14.87% , the lowest is $13.61 1.73% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $14.51 | 83.21% |
|---|---|---|
| 2025 | $15.31 | 5.51% |
| 2026 | $17.05 | 11.37% |
| 2027 | $19.87 | 16.54% |
| 2028 | $17.96 | 9.61% |
P/E ratio
| Current | 36.29 | 45.16% |
|---|---|---|
| 2025 | 32.83 | 9.54% |
| 2026 | 29.48 | 10.20% |
| 2027 | 25.30 | 14.18% |
Based on analysts' sales estimates for 2025, the Synopsys stock is valued at an EV/Sales of 10.71 and an P/S ratio of 11.32 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 11.86 | 21.25% |
|---|---|---|
| 2025 | 10.71 | 9.70% |
| 2026 | 9.54 | 10.91% |
| 2027 | 8.47 | 11.23% |
| 2028 | 7.75 | 8.46% |
| 2029 | 6.89 | 11.14% |
| 2030 | 6.42 | 6.85% |
| 2031 | 5.75 | 10.32% |
| 2032 | 5.21 | 9.54% |
P/S ratio
| Current | 12.54 | 18.23% |
|---|---|---|
| 2025 | 11.32 | 9.69% |
| 2026 | 10.09 | 10.91% |
| 2027 | 8.95 | 11.23% |
| 2028 | 8.20 | 8.46% |
| 2029 | 7.28 | 11.14% |
| 2030 | 6.78 | 6.85% |
| 2031 | 6.08 | 10.32% |
| 2032 | 5.50 | 9.54% |
Current Synopsys Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Rosenblatt |
Buy
➜
Buy
|
Unchanged | May 29 2025 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | May 29 2025 |
| Needham |
Buy
➜
Buy
|
Unchanged | May 29 2025 |
| Keybanc |
Overweight
➜
Overweight
|
Unchanged | May 20 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Apr 16 2025 |
| Mizuho |
Outperform
➜
Outperform
|
Unchanged | Apr 15 2025 |
| Keybanc |
Overweight
➜
Overweight
|
Unchanged | Apr 15 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Rosenblatt:
Buy
➜
Buy
|
May 29 2025 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
May 29 2025 |
|
Unchanged
Needham:
Buy
➜
Buy
|
May 29 2025 |
|
Unchanged
Keybanc:
Overweight
➜
Overweight
|
May 20 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Apr 16 2025 |
|
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Apr 15 2025 |
|
Unchanged
Keybanc:
Overweight
➜
Overweight
|
Apr 15 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
